Nylim GBL Ety R&D LDR ETF-UiWRNDETF
13F holders, Q1 2025 (March 31)3holders −1
0new positions
1sold out
$29.52avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($5.6M), Jane Street Group, LLC ($533K) and UBS Group AG ($5K).
- Company
- Nylim GBL Ety R&D LDR ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q1 2025)
- CUSIP
- 45409B255
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $324 |
All 13F filers, Q4 2024 → Q1 2025: 1,099 shares bought and 11 shares sold, net +1,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $5.6M |
| Jane Street Group, LLC | 0.00% | Add +6.5% | 18,059 | $533K |
| UBS Group AG | 0.00% | No change | 160 | $5K |
"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.